BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22343919)

  • 1. Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis.
    Pean P; Nerrienet E; Madec Y; Borand L; Laureillard D; Fernandez M; Marcy O; Sarin C; Phon K; Taylor S; Pancino G; Barré-Sinoussi F; Scott-Algara D;
    Blood; 2012 Apr; 119(14):3315-20. PubMed ID: 22343919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the NK Cell Repertoire Related to Initiation of TB Treatment and Onset of Immune Reconstitution Inflammatory Syndrome in TB/HIV Co-infected Patients in Rio de Janeiro, Brazil-ANRS 12274.
    Giacoia-Gripp CBW; Cazote ADS; da Silva TP; Sant'Anna FM; Schmaltz CAS; Brum TS; de Matos JA; Silva J; Benjamin A; Pilotto JH; Rolla VC; Morgado MG; Scott-Algara D
    Front Immunol; 2019; 10():1800. PubMed ID: 31456797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
    Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
    AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
    Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS.
    Goovaerts O; Massinga-Loembé M; Ondoa P; Ceulemans A; Worodria W; Mayanja-Kizza H; Colebunders R; Kestens L;
    PLoS One; 2019; 14(4):e0215991. PubMed ID: 31022273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection.
    Conradie F; Foulkes AS; Ive P; Yin X; Roussos K; Glencross DK; Lawrie D; Stevens W; Montaner LJ; Sanne I; Azzoni L
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):309-18. PubMed ID: 21826013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Activation of γδ T Cells and the γδ2
    Pean P; Nouhin J; Ratana M; Madec Y; Borand L; Marcy O; Laureillard D; Fernandez M; Barré-Sinoussi F; Weiss L; Scott-Algara D
    Front Immunol; 2019; 10():2018. PubMed ID: 31507608
    [No Abstract]   [Full Text] [Related]  

  • 9. Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive persons.
    Quiroga MF; Angerami MT; Santucci N; Ameri D; Francos JL; Wallach J; Sued O; Cahn P; Salomón H; Bottasso O
    PLoS One; 2012; 7(3):e33061. PubMed ID: 22431997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of monocytes in the development of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome.
    Tran HT; Van den Bergh R; Vu TN; Laukens K; Worodria W; Loembé MM; Colebunders R; Kestens L; De Baetselier P; Raes G;
    Immunobiology; 2014 Jan; 219(1):37-44. PubMed ID: 23958034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-specific interferon-gamma responses and innate cytokine balance in TB-IRIS.
    Goovaerts O; Jennes W; Massinga-Loembé M; Ceulemans A; Worodria W; Mayanja-Kizza H; Colebunders R; Kestens L;
    PLoS One; 2014; 9(11):e113101. PubMed ID: 25415590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients.
    Valin N; Pacanowski J; Denoeud L; Lacombe K; Lalande V; Fonquernie L; Girard PM; Meynard JL
    AIDS; 2010 Jun; 24(10):1519-25. PubMed ID: 20549841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB.
    Haridas V; Pean P; Jasenosky LD; Madec Y; Laureillard D; Sok T; Sath S; Borand L; Marcy O; Chan S; Tsitsikov E; Delfraissy JF; Blanc FX; Goldfeld AE;
    AIDS; 2015 Jan; 29(3):263-73. PubMed ID: 25486415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Repertoire Restoration in TB/HIV Co-Infected Individuals Experienced an Immune Reconstitution Syndrome (CAMELIA Trial, ANRS 12153).
    Pean P; Madec Y; Nerrienet E; Borand L; Laureillard D; Fernandez M; Marcy O; Scott-Algara D;
    Pathogens; 2023 Oct; 12(10):. PubMed ID: 37887757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients.
    da Silva TP; Giacoia-Gripp CBW; Schmaltz CA; Sant'Anna FM; Saad MH; Matos JA; de Lima E Silva JCA; Rolla VC; Morgado MG
    BMC Infect Dis; 2017 Sep; 17(1):606. PubMed ID: 28874142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome.
    Meintjes G; Wilkinson KA; Rangaka MX; Skolimowska K; van Veen K; Abrahams M; Seldon R; Pepper DJ; Rebe K; Mouton P; van Cutsem G; Nicol MP; Maartens G; Wilkinson RJ
    Am J Respir Crit Care Med; 2008 Nov; 178(10):1083-9. PubMed ID: 18755923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Goovaerts O; Jennes W; Massinga-Loembé M; Ondoa P; Ceulemans A; Vereecken C; Worodria W; Mayanja-Kizza H; Colebunders R; Kestens L;
    PLoS One; 2015; 10(7):e0133924. PubMed ID: 26208109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TB-IRIS pathogenesis and new strategies for intervention: Insights from related inflammatory disorders.
    Cevaal PM; Bekker LG; Hermans S
    Tuberculosis (Edinb); 2019 Sep; 118():101863. PubMed ID: 31561185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of T-Lymphocyte Activation Related to Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in Persons With Advanced HIV.
    Tibúrcio R; Barreto-Duarte B; Naredren G; Queiroz ATL; Anbalagan S; Nayak K; Ravichandran N; Subramani R; Antonelli LRV; Satagopan K; Anbalagan K; Porter BO; Sher A; Swaminathan S; Sereti I; Andrade BB
    Front Immunol; 2021; 12():757843. PubMed ID: 34691079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant Natural Killer T-cell Dynamics in Human Immunodeficiency Virus-associated Tuberculosis.
    Walker NF; Opondo C; Meintjes G; Jhilmeet N; Friedland JS; Elkington PT; Wilkinson RJ; Wilkinson KA
    Clin Infect Dis; 2020 Apr; 70(9):1865-1874. PubMed ID: 31190065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.